-
TRUSTED AU LABORATORY
-
26 Mark Rd. Elizabeth South, SA - 5112
-
Same day delivery
Pull the syringe to:
(0.100ml)
This calculator is provided as a reference tool for research purposes only. Always follow your institution’s safety protocols when handling research compounds.
Selank 10mg is a synthetic research peptide studied in relation to neuropeptide signalling, tuftsin analogue research, GABAergic pathway models, stress-response research and broader neuroscience research contexts.
Selank is commonly described in research literature as a synthetic analogue of tuftsin, a naturally occurring immunomodulatory peptide. It is generally discussed as a heptapeptide, meaning it contains seven amino acids. PubChem lists Selank with the molecular formula C33H57N11O9.
This product is supplied for laboratory research use only. It is not a medicine, supplement, anxiety treatment, mood product, nootropic product, sleep product, cognitive enhancer or injectable product for human use.
| Product Detail | Information |
|---|---|
| Product name | Selank |
| Common research names | TP-7, Selank peptide, tuftsin analogue |
| Size | 10mg |
| Product type | Research peptide |
| Research category | Neuropeptide Research / Cognitive Pathway Research |
| Common research interest | GABAergic signalling, stress-response models, neuropeptide pathway research |
| Peptide type | Synthetic heptapeptide tuftsin analogue |
| Form | Lyophilised powder |
| Intended use | Laboratory research only |
| Human use | Not for human consumption, administration, anxiety treatment, cognitive use or injection |
| Documentation | Certificate of Analysis should be checked before use |
| Component | Research Class | General Research Role |
| Selank | Synthetic neuropeptide research peptide | Studied in relation to stress-response and GABAergic pathway research |
| Tuftsin analogue structure | Modified peptide based on tuftsin-related research | Studied in neuroimmune and behavioural research models |
| Heptapeptide structure | Seven-amino-acid peptide | Commonly discussed as Thr-Lys-Pro-Arg-Pro-Gly-Pro |
| Molecular formula | C33H57N11O9 | Listed in PubChem for Selank |
| Neuropeptide pathway interest | GABAergic and stress-response research | Studied in relation to anxiety-like behaviour models and gene expression research |
| Lyophilised peptide preparation | Freeze-dried peptide format | Supports stability before reconstitution when stored correctly |
Product identity, sequence, purity, salt form and batch information should always be confirmed through supplier documentation and the Certificate of Analysis. Researchers should not rely on product name alone when confirming peptide identity.
Selank is studied as a tuftsin-derived neuropeptide research compound. In research settings, it is commonly examined for its relationship with stress-response models, GABAergic signalling, neuroimmune pathway research, gene expression and behaviour models.
A PubMed-indexed animal study describes Selank and other tuftsin-family peptides being tested in stress-related behavioural models in mice and rats. Another research article discusses Selank’s possible relationship with GABAergic signalling and gene expression pathways, including proposed GABA-A receptor modulation mechanisms.
This should be understood as laboratory and preclinical research context only. It should not be used as a claim that a research-use Selank 10mg vial is approved, safe or effective for anxiety, stress, mood, cognition, sleep or human performance.
| Research Area | Selank |
| Main research category | Neuropeptide research |
| Parent pathway context | Tuftsin analogue research |
| Peptide length | Heptapeptide |
| Common pathway interest | GABAergic signalling and stress-response research |
| Neuroimmune interest | Tuftsin-related immunomodulatory pathway research |
| Behavioural research interest | Anxiety-like behaviour and stress-adaptation models |
| Evidence limitation | Mostly laboratory, preclinical and limited regional research contexts |
| Product limitation | Research use only, not approved for human use |
| Feature | Selank | Semax |
| Research class | Tuftsin analogue neuropeptide | ACTH fragment analogue neuropeptide |
| Common research focus | Stress-response, GABAergic and neuroimmune pathway research | Neurotrophic, cognitive and ACTH-fragment pathway research |
| Peptide type | Synthetic heptapeptide | Synthetic peptide analogue |
| Common SEO risk | Being marketed as an anxiety, mood or sleep peptide | Being marketed as a nootropic or cognitive enhancer |
| Safer positioning | Tuftsin analogue research peptide | ACTH-fragment research peptide |
| Human-use claim | Not appropriate for research-use products | Not appropriate for research-use products |
| Feature | Selank | DSIP |
| Research class | Tuftsin analogue neuropeptide | Delta sleep-inducing peptide |
| Main research interest | GABAergic, stress-response and neuroimmune pathway research | Sleep architecture, circadian and neuropeptide pathway research |
| Common online claim risk | Anxiety, stress relief, focus and calm | Sleep, relaxation and recovery |
| Safer positioning | Neuropeptide stress-response research | Neuropeptide sleep-architecture research |
| Human-use claim | Not appropriate | Not appropriate |
| Common Online Claim | Safer Research-Use Wording |
| Anxiety relief | Studied in stress-response and anxiety-like behaviour research models |
| Calming effect | Studied in relation to GABAergic pathway research |
| Mood support | Better framed as neuropeptide and stress-response research |
| Focus | Not an approved or appropriate product claim |
| Nootropic | Better framed as cognitive pathway research, not a human benefit |
| Sleep support | Not an approved or appropriate product claim |
| Benzodiazepine alternative | Misleading and not appropriate for research-use material |
| Stress reduction | Better framed as stress-adaptation research models |
Selank 10mg is not intended to diagnose, treat, cure or prevent any disease. It is not supplied for anxiety, stress relief, mood support, depression, sleep, focus, cognition, nootropic use, relaxation, anti-ageing, performance enhancement or general wellness use.
All information on this page is provided for laboratory research and product handling context only.
There is no universal recommended dilution for Selank 10mg. Dilution depends on the research protocol, required working concentration, assay design, solvent compatibility, storage method and validated laboratory procedure.
For research concentration planning only, the basic formula is:
Total peptide amount divided by diluent volume equals final concentration.
| Diluent Added to 10mg Vial | Final Concentration |
| 1mL | 10mg/mL |
| 2mL | 5mg/mL |
| 2.5mL | 4mg/mL |
| 3mL | 3.33mg/mL |
| 4mL | 2.5mg/mL |
| 5mL | 2mg/mL |
| 10mL | 1mg/mL |
These are research concentration examples only. They are not human dosing instructions and must not be used to calculate injection quantities.
Before handling Selank 10mg in a laboratory setting, make sure all materials, documentation and clean handling conditions are prepared.
| Item | Purpose |
| Product vial | Contains lyophilised Selank peptide |
| Certificate of Analysis | Confirms batch-level testing information |
| Suitable research-grade diluent | Used to prepare a working research solution |
| Sterile lab consumables | Helps reduce contamination risk |
| Personal protective equipment | Gloves, lab coat and eye protection |
| Alcohol wipes or approved disinfectant | Used for surface and vial-top preparation |
| Laboratory labels | Records concentration, date, batch and handler details |
| Cold storage access | Supports correct storage after preparation |
| Disposal container | Used for compliant laboratory waste disposal |
The following is a general laboratory handling framework only. Always follow the product Certificate of Analysis, supplier documentation, SDS, institutional procedures and validated research protocol.
Check the product label, batch number, Certificate of Analysis and storage requirements before handling the vial.
Use a clean laboratory workspace. Wear appropriate PPE and disinfect the bench surface, vial top and any required equipment.
If the vial has been stored cold, allow it to equilibrate according to laboratory procedure before opening or reconstitution. Avoid condensation entering the vial.
Add the selected research-grade diluent slowly down the inside wall of the vial. Avoid forceful spraying directly onto the lyophilised powder.
Gently swirl or roll the vial until the powder is dissolved. Avoid aggressive shaking, unnecessary vortexing or foaming unless a validated protocol specifically allows it.
Check the solution for cloudiness, visible particles, unusual colour changes or undissolved material. If anything appears abnormal, quarantine the vial and check supplier documentation.
Label the vial or aliquots with the product name, concentration, diluent used, date prepared, batch number and researcher initials.
Place the reconstituted solution into the required storage condition as soon as possible. Avoid unnecessary warming, cooling or repeated freeze-thaw cycles.
Some lyophilised peptide products may take time to fully hydrate. Dissolution should always be handled gently and according to laboratory protocol.
| Issue | What It May Indicate | Safer Response |
| Powder clinging to vial wall | Static or lyophilisation residue | Allow more contact time with diluent |
| Small particles remain | Incomplete hydration | Continue gentle swirling |
| Cloudy solution | Possible incompatibility or contamination | Stop and check documentation |
| Foaming | Too much agitation | Let the solution settle and avoid shaking |
| Colour change | Possible degradation or contamination | Do not continue without supplier guidance |
| Storage Factor | Guidance |
| Product form | Lyophilised powder |
| Storage condition | Follow supplier label and Certificate of Analysis |
| Light exposure | Protect from unnecessary light exposure |
| Moisture exposure | Keep sealed until use |
| Temperature changes | Avoid repeated temperature cycling |
| Handling | Minimise unnecessary opening or vial puncture |
| Storage Factor | Guidance |
| Storage condition | Follow validated research protocol |
| Labelling | Record concentration, date, diluent and batch number |
| Freeze-thaw cycles | Avoid repeated freeze-thaw exposure |
| Aliquoting | Use small research aliquots where appropriate |
| Contamination control | Use clean laboratory technique |
| Light exposure | Protect from unnecessary light exposure where required |
| Disposal | Dispose according to laboratory waste procedures |
Peptides may be sensitive to temperature, light, pH, agitation and contamination. Storage conditions should be confirmed through supplier documentation or the laboratory’s validated method.
This page does not provide human dosing, injection instructions, injection schedules or administration guidance.
Selank 10mg is not supplied for human or animal administration. It is a laboratory research-use product only.
For research settings, any measured aliquots should be prepared according to the concentration required by the approved research protocol. All calculations should be checked, documented and traceable.
| Planning Item | What to Record |
| Final concentration | Total peptide amount and diluent volume |
| Working solution | Concentration used in the research protocol |
| Aliquot volume | Volume transferred into each labelled lab tube |
| Batch details | Product batch, CoA and preparation date |
| Storage location | Fridge, freezer or other controlled storage area |
| Handler details | Researcher name or initials |
| Preparation date | Date and time of reconstitution |
| Disposal date | When the aliquot should no longer be used |
| Strength check | Confirmation that the 10mg vial strength matches the approved research protocol |
Correct handling is important for research consistency, contamination control and product traceability. Most mistakes occur when products are not labelled clearly, concentration calculations are not recorded or storage conditions are not followed.
Because Selank is commonly discussed online in relation to anxiety, stress, cognition, sleep and mood, product pages should avoid wording that could be interpreted as encouraging human self-use, injection, mental health treatment or nootropic use.
| Always | Why It Matters |
| Check the Certificate of Analysis | Confirms batch-level information |
| Use PPE | Reduces contamination and exposure risk |
| Label every vial and aliquot | Prevents mix-ups |
| Record concentration calculations | Supports traceability |
| Use clean laboratory technique | Reduces contamination risk |
| Follow institutional protocols | Keeps handling consistent and auditable |
| Store according to documentation | Helps protect peptide integrity |
| Dispose of lab waste correctly | Supports safety and compliance |
| Use research-use wording only | Reduces misleading human-use interpretation |
| Clearly separate research pathways from human benefit claims | Avoids unsafe or misleading product positioning |
| Never | Why It Is Risky |
| Never use for self-injection | Product is research use only |
| Never sell or promote as an anxiety treatment | Creates human-use and compliance risk |
| Never make stress-relief or mood claims | Not an approved or appropriate product claim |
| Never make nootropic or cognitive enhancement claims | Not an approved or appropriate product claim |
| Never describe it as a benzodiazepine alternative | Misleading and clinically inappropriate |
| Never make sleep or relaxation claims | Not an approved or appropriate product claim |
| Never imply mental health treatment | Not suitable for a research-use product page |
| Never assume purity without CoA | Batch quality must be documented |
| Never use a damaged or unlabelled vial | Identity and sterility may be uncertain |
| Never shake aggressively | May affect peptide integrity |
| Never use random solvents | May damage the peptide or alter research results |
| Never leave reconstituted product unlabelled | Creates traceability risk |
| Never rely on social media protocols | They may be inaccurate, unsafe or non-compliant |
The table below is for concentration planning only. It does not represent dosage, injection quantity or recommended administration.
| Total Vial Amount | Diluent Volume | Final Concentration |
| 10mg | 1mL | 10mg/mL |
| 10mg | 2mL | 5mg/mL |
| 10mg | 2.5mL | 4mg/mL |
| 10mg | 3mL | 3.33mg/mL |
| 10mg | 4mL | 2.5mg/mL |
| 10mg | 5mL | 2mg/mL |
| 10mg | 10mL | 1mg/mL |
If a researcher adds 2mL of suitable research-grade diluent to a 10mg vial, the resulting concentration is 5mg/mL.
This calculation is for research concentration planning only. It is not a human or animal dosing example.
Selank is a synthetic research peptide commonly described as a tuftsin analogue. It is studied in relation to neuropeptide signalling, GABAergic pathway research, stress-response models and neuroimmune research.
Yes. Selank is commonly described as a synthetic heptapeptide, meaning it is made up of seven amino acids.
Selank is commonly studied in relation to GABAergic signalling, stress-response biology, neuropeptide pathway research and gene expression models. Research literature has discussed possible involvement of the GABAergic system in Selank-related anxiolytic mechanisms.
This research product is not approved or supplied for anxiety, stress relief, mood support, sleep, cognitive enhancement, nootropic use or human administration. It should be described only as a laboratory research product.
No. Selank is commonly discussed as a tuftsin analogue, while Semax is commonly discussed as an ACTH fragment analogue. They are different neuropeptide research products with different research positioning.
No. Selank is usually positioned around tuftsin analogue, GABAergic and stress-response pathway research. DSIP is usually positioned around delta sleep-inducing peptide and sleep-architecture research.
A Certificate of Analysis provides batch-level testing information. It helps researchers verify product identity, purity, salt form and quality documentation before use in a research setting.
| Resource | Why It Is Useful |
| PubChem Selank compound profile | Useful background on Selank identity and molecular formula. |
| PubMed Selank and tuftsin-family peptide study | Useful background on preclinical stress-related behavioural research. |
| Selank gene expression and GABAergic pathway research | Useful background on proposed GABAergic pathway and gene expression mechanisms. |
Research Use Only: Selank 10mg is supplied strictly for laboratory research purposes. It is not intended for human or animal consumption, injection, therapeutic use, cosmetic use, diagnostic use, anxiety, stress relief, mood support, sleep, nootropic use, cognitive enhancement, relaxation, anti-ageing, body enhancement or performance enhancement. Information on this page is provided for research education and product handling context only. Always follow applicable laws, institutional procedures, supplier documentation and qualified laboratory protocols.
